DUBLIN--(BUSINESS WIRE)--ICON Firecrest, a provider of integrated Web-based services that optimise clinical trial performance, received a 2014 Global Award for its art and technique: animation entry, “Firecrest Through the Body.” This 3D animated video was created and developed by a team of 3D graphic designers and pharmacologists at Firecrest. It features realistic views of systems inside the body and it showcases the diverse range of medical areas in which Firecrest has expertise. Firecrest’s 3D animations are used to supplement study-specific training programs that have been proven to reinforce study consistency, quality and compliance.
“I’m extremely proud to work with such a talented team,” said Frances Abeton, vice president. “This award represents our dedication to providing the best training and resources available that help pharmaceutical and biotech companies and their investigators and clinical research teams improve efficiencies and be more patient centric throughout the clinical development process of new products.”
The Global Awards are the world’s most coveted health care communications awards. The Global Awards receives entries from health care corporations, hospitals, advertising agencies, production companies and design studios that produce communications for medical, pharmaceutical, health care and wellness products and services.
Learn more about ICON Firecrest and its innovative suite of study tools for training, communication, compliance, patient education and more.
About Firecrest
Firecrest provides integrated, Web-based
innovations and services that help sites conduct research more
efficiently and effectively, and gives sponsors tools for optimising
trial performance. No matter the complexity or scope of your research
program, Firecrest improves study performance from startup to closeout —
Firecrest is your Virtual Study Expert. Learn more at www.iconplc.com/technology/firecrest.
About ICON plc
ICON plc is a global provider of outsourced
development services to the pharmaceutical, biotechnology and medical
device industries. The company specialises in the strategic development,
management and analysis of programs that support clinical development —
from compound selection to Phase I-IV clinical studies. ICON currently
has approximately 11,000 employees, operating in 38 countries. Learn
more at www.iconplc.com.
